Research Paper Volume 15, Issue 17 pp 8744—8769
Comprehensive analysis and experimental validation reveal elevated CLCN4 is a promising biomarker in endometrial cancer
Figure 3. The association between CLCN4 expression and cancer pathological grades (stage I, II, III, IV). (A) ACC. (B) KIRC. (C) LUAD. (D) PAAD. (E) TGCT. (F) THCA.